Envista Holdings Corporation (NVST)
NYQ · Medical Instruments & Supplies
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Peers in Medical Instruments & Supplies
All in industry →Intuitive Surgical, Inc.
Medline Inc.
Becton, Dickinson and Company
Alcon Inc.
ResMed Inc.
West Pharmaceutical Services, Inc.
The Cooper Companies, Inc.
Align Technology, Inc.
Solventum Corporation
Baxter International Inc.
Recent press releases
April 2026
Envista Plans Ormco Divestiture to Focus on Core Dental Business
# 🧾 What This Document Is This is Envista's **Annual Report to Shareholders (ARS)**. Think of it as the company's official "year-in-review" book, sent directly to investors. It combines a glossy, visual overview with the serious, audited financial numbers. Unlike a standard 10-K filing, the ARS is
Envista Holdings Corp — DEF 14A Filing
# 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for **Envista Holdings Corp (NVST)**. Think of it as a detailed invitation and report for the company's shareholders. It explains what will be voted on at the 2026 Annual Meeting and provides all the information shareholde
SEC filings
All filings →Insider trades
All insider trades →Envista Holdings Corporation has no reported insider trades in the last 90 days.